Literature DB >> 6363541

The fate of E. coli lipopolysaccharide after the uptake of E. coli by murine macrophages in vitro.

R L Duncan, D C Morrison.   

Abstract

The fate of bacterial lipopolysaccharide (LPS) after the uptake of Escherichia coli by macrophages in vitro was studied. The LPS of the galactose epimerase-deficient E. coli J5 mutant was specifically radiolabeled with [3H]galactose by growing the organism in a basic salts medium containing galactose. Control bacteria were uniformly radiolabeled by growth in [14C]glucose and unlabeled galactose-containing medium. Surface constituents of E. coli were also labeled with 125I. After in vitro phagocytosis of labeled E. coli by murine peritoneal exudate macrophages, the rate of exocytosis of LPS, as assessed by release of 3H over a 72-hr period, was considerably reduced in comparison with other bacterial constituents (14C and 125I release). The [3H]galactose-labeled material exocytosed from macrophages and that remaining intracellularly (obtained from macrophage lysates) were isolated by cesium chloride (CsCl) density gradients and were shown to have altered density profiles as compared with purified E. coli LPS. The macrophage-"processed" [3H] galactose-containing fractions from CsCl density gradients of culture supernatants or macrophage lysates were capable of clotting Limulus amebocyte lysate. The [3H]galactose material obtained from 48-hr macrophage lysates and culture supernatants could also induce a lethal response in actinomycin D-treated mice. These data suggest that bacterial LPS may be selectively retained by the macrophage and that the post-phagocytic events that result in bacterial degradation are not accompanied by the degradation of LPS. Furthermore, although the LPS may be modified by the macrophage, it retains its biologic activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363541

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria.

Authors:  N Hiki; D Berger; C Prigl; E Boelke; H Wiedeck; M Seidelmann; L Staib; M Kaminishi; T Oohara; H G Beger
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

2.  Complement-mediated lipopolysaccharide release and outer membrane damage in Escherichia coli J5: requirement for C9.

Authors:  A M O'Hara; A P Moran; R Würzner; A Orren
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

3.  The transport and inactivation kinetics of bacterial lipopolysaccharide influence its immunological potency in vivo.

Authors:  Mingfang Lu; Robert S Munford
Journal:  J Immunol       Date:  2011-08-17       Impact factor: 5.422

4.  Uptake and subcellular localization of bacterial lipopolysaccharide in the adrenal gland.

Authors:  J C Mathison; R J Ulevitch
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

5.  The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide.

Authors:  B J Van Lenten; A M Fogelman; M E Haberland; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

6.  Reactivity of the human antiendotoxin immunoglobulin M monoclonal antibody HA-1A with lipopolysaccharides from rough and smooth gram-negative organisms.

Authors:  M A Mascelli; B Frederick; T Ely; D S Neblock; D J Shealy; K Y Pak; P E Daddona
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Evidence for lipopolysaccharide as the predominant proinflammatory mediator in supernatants of antibiotic-treated bacteria.

Authors:  M C Leeson; Y Fujihara; D C Morrison
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Susceptibility of lipopolysaccharide-responsive and -hyporesponsive ItyS Mice to infection with rough mutants of Salmonella typhimurium.

Authors:  I Mattsby-Baltzer; B Ahlström; L Edebo; P de Man
Journal:  Infect Immun       Date:  1996-04       Impact factor: 3.441

9.  Uptake and deacylation of bacterial lipopolysaccharides by macrophages from normal and endotoxin-hyporesponsive mice.

Authors:  R S Munford; C L Hall
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

10.  Bacterial antigen immunolabeling in macrophages after phagocytosis and degradation of Bacillus subtilis.

Authors:  T Lang; M T Tassin; A Ryter
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.